Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • FAQs

    Global Diabetes Care Devices Market size was valued at USD 31.54 Billion in 2024 poised to grow between USD 34.29 Billion in 2025 to USD 66.83 Billion by 2033, growing at a CAGR of 8.7% in the forecast period (2026–2033).

    The global diabetes care devices market outlook is highly competitive, with key players like Abbott, Medtronic, Dexcom, Roche, and Ascensia Diabetes Care leading innovation. Abbott focuses on expanding its FreeStyle Libre CGM system globally. Dexcom emphasizes AI integration and wearable tech partnerships. Medtronic advances closed-loop insulin delivery. Roche invests in digital diabetes management platforms. These companies compete through technological innovation, strategic collaborations, and regional expansion to strengthen their market presence. 'Abbott Laboratories (USA)', 'Medtronic plc (Ireland)', 'Dexcom, Inc. (USA)', 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Ascensia Diabetes Care (Switzerland)', 'Sanofi (France)', 'Novo Nordisk A/S (Denmark)', 'Ypsomed Holding AG (Switzerland)', 'Insulet Corporation (USA)', 'Tandem Diabetes Care, Inc. (USA)', 'Eli Lilly and Company (USA)', 'B. Braun Melsungen AG (Germany)', 'Arkray, Inc. (Japan)', 'Terumo Corporation (Japan)', 'Senseonics Holdings, Inc. (USA)'

    The increasing global prevalence of diabetes, particularly Type 2, is a primary driver of the global diabetes care devices market growth. Sedentary lifestyles, aging populations, and unhealthy diets are fuelling diagnosis rates. This growing patient base demands consistent monitoring and insulin management, boosting demand for glucose monitors and insulin delivery devices worldwide.

    Expansion of Remote Patient Monitoring and Telehealth: The integration of diabetes care devices with telehealth platforms is accelerating. Continuous glucose monitors and insulin pumps now sync with cloud-based systems, allowing healthcare providers to monitor patients remotely. This global diabetes care devices market trend enhances chronic disease management, reduces hospital visits, and supports better outcomes through timely data sharing and virtual consultations.

    What Type of Healthcare Infrastructure Supports the Market in North America?

    Feedback From Our Clients

    Global Diabetes Care Devices Market

    Report ID: SQMIG35G2341

    $5,300
    BUY NOW